United Therapeutics completes enrolment for TETON-PPF trial

Trial StartTyvasoNeutral

AI Analysis

Summary

United Therapeutics has completed patient enrolment for its TETON-PPF study evaluating the safety and efficacy of nebulised Tyvaso for pulmonary fibrosis treatment.

Clinical Trial Data

Outcome Details

Enrolment completed for TETON-PPF trial

Importance:4/10

Sentiment:

0.20

clinical trialenrollment milestoneTyvasoPPFUnited Therapeutics

Related Companies

$UTHR

Read the original article

Published by Clinical Trials Arena on August 18, 2026 9:48 AM

Read Original